Skip to main content

Medication Continuation Following Inpatient Psychiatric Discharge

CBE ID
3205
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

This measure assesses whether patients discharged from an inpatient psychiatric facility (IPF) with major depressive disorder (MDD), schizophrenia, or bipolar disorder filled a prescription for evidence-based medication within 2 days prior to discharge and 30 days post-discharge. This measure evaluates admissions over a two-year period.

        • 1.14 Numerator

          The numerator for the measure includes:
          • Discharges with a principal diagnosis of MDD in the denominator population for which patients were dispensed evidence-based outpatient medication within 2 days prior to discharge through 30 days post-discharge
          • Discharges with a principal diagnosis of schizophrenia in the denominator population for which patients were dispensed evidence-based outpatient medication within 2 days prior to discharge through 30 days post-discharge
          • Discharges with a principal diagnosis of bipolar disorder in the denominator population for which patients were dispensed evidence-based outpatient medication within 2 days prior to discharge through 30 days post-discharge

        • 1.15 Denominator

          The target population for this measure is Medicare fee-for-service (FFS) beneficiaries with Part D coverage aged 18 years and older discharged from an inpatient psychiatric facility with a principal diagnosis of MDD, schizophrenia, or bipolar disorder.

        • Exclusions

          The denominator for this measure excludes discharged patients who:
          • Received electroconvulsive (ECT) during the inpatient stay or follow-up period
          • Received transcranial stimulation (TMS) during the inpatient stay or follow-up period
          • Were pregnant at discharge
          • Had a secondary diagnosis of delirium at discharge
          • Had a principal diagnosis of schizophrenia with a secondary diagnosis of dementia at discharge

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Behavioral Health and Substance Use Fall Cycle 2020
          Initial Endorsement
          Last Updated
          Removal Date